-->

Tag: Innovative Immunotherapy for Myeloma

Home / Innovative Immunotherapy for Myeloma

Categories

Clinical trial on CAR-T Cell therapy for patients with BCMA/TACI-positive relapsed and/or refractory multiple myeloma

Brief Summary: A study of APRIL CAR-T cells therapy for patients with BCMA/TACI positive relapsed and/or refractory multiple myeloma   Detailed Description: This i...
innovative-immunotherapy-for-myeloma

Anti-BCMA CAR T-Cell therapy clinical trials for relapse/refractory Immune thrombocytopenia(R/R ITP)

March 2023: Immune thrombocytopenia (ITP) is a disorder that can lead to easy or excessive bruising and bleeding. Approximately two-thirds of patients achieve remission after/during first-line therap...
innovative-immunotherapy-for-myeloma

Scan the code